Cargando…
Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial
OBJECTIVES: CEQUEL (Comparative Evaluation of QUEtiapine plus Lamotrigine combination versus quetiapine monotherapy [and folic acid versus placebo] in bipolar depression) was a double‐blind, randomized, placebo‐controlled, parallel group, 2×2 factorial trial that examined the effect of adding lamotr...
Autores principales: | Tunbridge, EM, Attenburrow, MJ, Gardiner, A, Rendell, JM, Hinds, C, Goodwin, GM, Harrison, PJ, Geddes, JR |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697684/ https://www.ncbi.nlm.nih.gov/pubmed/28833962 http://dx.doi.org/10.1111/bdi.12531 |
Ejemplares similares
-
Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)
por: Simon, Judit, et al.
Publicado: (2018) -
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
por: Saunders, Kate E. A., et al.
Publicado: (2016) -
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development
por: Cipriani, A, et al.
Publicado: (2016) -
The Emerging Neurobiology of Bipolar Disorder
por: Harrison, Paul J., et al.
Publicado: (2018) -
Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data
por: Nzeyimana, Antoine, et al.
Publicado: (2018)